Soligenix
SNGX
#11002
Rank
C$10.28 M
Marketcap
C$0.47
Share price
0.51%
Change (1 day)
-75.25%
Change (1 year)

Soligenix (SNGX) - Total assets

Total assets on the balance sheet as of March 2026 : C$9.76 Million

According to Soligenix's latest financial reports the company's total assets are C$9.76 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Soligenix - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31C$19.37 M-43.42%
2021-12-31C$34.24 M35.02%
2020-12-31C$25.36 M149.75%
2019-12-31C$10.15 M-28.94%
2018-12-31C$14.29 M19.04%
2017-12-31C$12 M-12.98%
2016-12-31C$13.79 M34.64%
2015-12-31C$10.24 M26.98%
2014-12-31C$8.07 M-8.28%
2013-12-31C$8.79 M88.05%
2012-12-31C$4.67 M-44.07%
2011-12-31C$8.36 M-9.71%
2010-12-31C$9.26 M-6.17%
2009-12-31C$9.87 M141.5%
2008-12-31C$4.08 M8.32%
2007-12-31C$3.77 M130.43%
2006-12-31C$1.63 M-58.28%
2005-12-31C$3.92 M-35.49%
2004-12-31C$6.08 M-24.95%
2003-12-31C$8.11 M-12.05%
2002-12-31C$9.22 M-47.58%
2001-12-31C$17.58 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
C$278.35 B 2,851,774.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$283.58 B 2,905,308.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$207.68 B 2,127,700.95%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
C$25.62 M 162.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$10.47 M 7.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$56.19 B 575,648.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.57 B 16,032.57%๐Ÿ‡บ๐Ÿ‡ธ USA